VSEE HEALTH, INC. Income Statement
VSEE|2 years of annual SEC 10-K data (FY2024-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 2 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$10M
FY2025
Gross Profit
$7M
68.9% gross margin
Operating Income
-$62M
FY2025
Net Income
-$58M
FY2025
VSEE HEALTH, INC. reported $10M in revenue and $58M in net loss for FY2025. Revenue increased 560.6% from FY2024 to FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $10.4M | $1.6M |
| Cost of Revenue | $3.2M | $1.9M |
| Gross Profit | $7.2M | $1.0M |
| SG&A Expense | $6.6M | $341.2K |
| Operating Income | -$62.2M | -$715.9K |
| Income Tax | -$1.6M | $1.8M |
| Net Income | -$57.7M | -$530.0K |
| EPS (Basic) | -$5.65 | -$0.05 |
| EPS (Diluted) | -$5.65 | -$0.05 |
| Shares Outstanding | 14.7M | 4.6M |
| Gross Margin | 68.9% | 63.5% |
| Operating Margin | -596.4% | -45.4% |
| Profit Margin | -553.7% | -33.6% |